Anna Castagna1, Alberto Albanese1. 1. IRCCS Fondazione Don Carlo Gnocchi (AC), Servizio di Analisi Funzione Locomotoria; Università Cattolica del Sacro Cuore (AA), Istituto di Neurologia; and IRCCS Istituto Clinico Humanitas (AA), Unità Operativa Neurologia, Rozzano, Milano.
Abstract
PURPOSE OF REVIEW: We provide a practical guide on the use of electromyography (EMG) and ultrasound (US) to assist botulinum neurotoxin (BoNT) treatment in patients with cervical dystonia (CD). RECENT FINDINGS: US and EMG guidance improve BoNT treatment in CD. Their use is particularly valuable for targeting deep neck muscles and managing complex cases. There is also evidence that adverse events are reduced when superficial or intermediate layer muscles are injected with assisted guidance. SUMMARY: A structured clinical approach, based on functional neck anatomy, guides CD assessment and BoNT treatment. Muscles are selected according to clinical, EMG and US findings. US provides anatomical visualization, while EMG complements by detecting muscle activity. We review here the current practice for assisted treatment of CD through BoNT cycles. We also describe how to recognize and manage the main adverse events.
PURPOSE OF REVIEW: We provide a practical guide on the use of electromyography (EMG) and ultrasound (US) to assist botulinum neurotoxin (BoNT) treatment in patients with cervical dystonia (CD). RECENT FINDINGS: US and EMG guidance improve BoNT treatment in CD. Their use is particularly valuable for targeting deep neck muscles and managing complex cases. There is also evidence that adverse events are reduced when superficial or intermediate layer muscles are injected with assisted guidance. SUMMARY: A structured clinical approach, based on functional neck anatomy, guides CD assessment and BoNT treatment. Muscles are selected according to clinical, EMG and US findings. US provides anatomical visualization, while EMG complements by detecting muscle activity. We review here the current practice for assisted treatment of CD through BoNT cycles. We also describe how to recognize and manage the main adverse events.
Authors: C Ertekin; I Aydogdu; Y Seçil; N Kiylioglu; S Tarlaci; T Ozdemirkiran Journal: J Neurol Neurosurg Psychiatry Date: 2002-10 Impact factor: 10.154
Authors: Martina Petracca; Maria Rita Lo Monaco; Tamara Ialongo; Enrico Di Stasio; Maria Luana Cerbarano; Loredana Maggi; Alessandro De Biase; Giulia Di Lazzaro; Paolo Calabresi; Anna Rita Bentivoglio Journal: J Neurol Date: 2022-09-06 Impact factor: 6.682
Authors: Harry Tucker; Foster Osei-Poku; Diane Ashton; Rachael Lally; Aaron Jesuthasan; Anna Latorre; Kailash P Bhatia; Jane E Alty; Christopher Kobylecki Journal: Mov Disord Clin Pract Date: 2021-03-16